The Perlmutter Cancer Center has made a commitment to translating scientific advances into novel treatments with the potential to directly benefit patients with genitourinary cancers. In the laboratory and clinic, investigators in the Genitourinary Oncology Research Program are collaborating to:
- Decipher the mechanisms of prostate and bladder carcinogenesis
- Develop new methods for diagnosing and treating bladder, prostate, and kidney cancers
- Effectively implement clinical trials for prostate, kidney, and bladder cancers based on novel therapeutic strategies.
- Provide optimal and personalized multidisciplinary treatment for genitourinary malignancies, as exemplified by the Smilow Comprehensive Prostate Cancer Center.
The program achieves its goals by:
- Identifying resources to support collaborative programs and individual members, in conjunction with the NYU Langone School of Medicine Center of Excellence in Urological Diseases
- Providing access to Perlmutter Cancer Center core facilities and program resources
- Hosting inter-programmatic seminars and conferences